The present invention relates to novel synthetic toll like receptor antagonist. The present invention in particular provides compounds, methods and compositions for specifically inhibiting immune stimulation involving TLR ligands, especially TLR-4. The compounds are potentially useful in treatment of inflammation, autoimmunity, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.

 
Web www.patentalert.com

< INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF

> Heterologous Protein Production Using The Twin Arginine Translocation Pathway

> PROTOPORPHYRINOGEN OXIDASE HAVING ACTIVITY OF IMPARTING RESISTANCE AGAINST ACIFLUORFEN AND GENE THEREOF

~ 00540